Results: 1-9 |
Results: 9

Authors: Althaus, M de Mey, C Ezan, E Ciecko-Michalska, I Kostka-Trabkal, E Goszcz, A Retzow, A
Citation: M. Althaus et al., Plasma and urine, pharmacokinetics of the dopamine agonist alpha-dihydroergocryptine in patients with hepatic dysfunction, INT J CL PH, 39(2), 2001, pp. 67-74

Authors: Minea, D Varga, I Falup-Pecurariu, C de Mey, C Retzow, A Althaus, M
Citation: D. Minea et al., Influence of the dopamine agonist alpha-dihydroergocryptine on the pharmacokinetics of levodopa in patients with Parkinson's disease, CLIN NEUROP, 24(4), 2001, pp. 235-238

Authors: de Mey, C Althaus, M Ezan, E Retzow, A
Citation: C. De Mey et al., Erythromycin increases plasma concentrations of alpha-dihydroergocryptine in humans, CLIN PHARM, 70(2), 2001, pp. 142-148

Authors: Wangemann, M Retzow, A Mazur, D Vens-Cappell, B
Citation: M. Wangemann et al., Study on the dose proportionality of the pharmacokinetics of sustained release sodium valproate, INT J CL PH, 38(8), 2000, pp. 395-401

Authors: Muller-Oerlinghausen, B Retzow, A Henn, FA Giedke, H Walden, J
Citation: B. Muller-oerlinghausen et al., Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: A prospective, randomized, double-blind, placebo-controlled, multicenter study, J CL PSYCH, 20(2), 2000, pp. 195-203

Authors: Althaus, M Retzow, A Castell, JV Gomez-Lechon, MJ Amalou, Z Rose, T Appel, K
Citation: M. Althaus et al., In vitro identification of the cytochrome P450 isoform responsible for themetabolism of alpha-dihydroergocryptine, XENOBIOTICA, 30(11), 2000, pp. 1033-1045

Authors: Retzow, A Althaus, M de Mey, C Mazur, D Vens-Cappell, B
Citation: A. Retzow et al., Study on the interaction of the dopamine agonist alpha-dihydroergocryptinewith the pharmacokinetics of digoxin, ARZNEI-FOR, 50(7), 2000, pp. 591-596

Authors: Wangemann, M Retzow, A Vens-Cappell, B
Citation: M. Wangemann et al., Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate, INT J CL PH, 37(2), 1999, pp. 100-108

Authors: Wangemann, M Retzow, A Evers, G Mazur, D Schug, B Blume, H
Citation: M. Wangemann et al., Bioavailability study of two carbamazepine containing sustained release formulations after multiple oral dose administration, ARZNEI-FOR, 48(12), 1998, pp. 1131-1137
Risultati: 1-9 |